StonvexLoading…
StonvexStonvexStonvexCore line items from CDLX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $34.32M | $212.33M | $161.44M | $114.48M |
Operating Income | $-8.27M | $-101.82M | $-95.72M | $-26.87M |
Net Income | $-4.48M | $-103.49M | $-95.24M | $-22.57M |
EPS (Diluted) | $-0.25 | $-1.95 | $-1.81 | $-0.43 |
Total Assets | $263.91M | $285.64M | $292.81M | $361.13M |
Total Liabilities | $267.91M | $292.15M | $297.51M | $302.43M |
Cash & Equivalents | $35.67M | $48.72M | $43.96M | $46.74M |
Free Cash Flow OCF − CapEx | $-5.67M | $8.81M | $-4.17M | $-5.92M |
Shares Outstanding | 54.51M | 54.51M | 51.26M | 51.26M |